Verlagslink DOI: | 10.1016/j.soard.2018.02.029 | Titel: | Longitudinal evaluation of efficacy, safety and nutritional status during one-year treatment with the duodenal-jejunal bypass liner | Sprache: | Englisch | Autorenschaft: | Riedel, Nina Laubner, Katharina Lautenbach, Anne Schön, Gerhard Schlensak, Matthias Stengel, Rainer Eberl, Thomas Dederichs, Frank Aberle, Jens Seufert, Jochen |
Erscheinungsdatum: | Jun-2018 | Zeitschrift oder Schriftenreihe: | Surgery for Obesity and Related Diseases | Zeitschriftenband: | 14 | Zeitschriftenausgabe: | 6 | Anfangsseite: | 769 | Endseite: | 779 | Zusammenfassung: | Abstract Background: The endoscopic duodenal-jejunal bypass liner (DJBL) represents a novel temporary endoscopic approach for treatment of obesity-associated type 2 diabetes. Recent results from the German DJBL registry confirmed substantial positive metabolic effects of the DJBL in type 2 diabetes. However, the last Food and Drug Administration trial was stopped due to a high occurrence of hepatic abscesses (3.5%). Objectives: Here, we analyzed time courses of development of co-morbidities, nutritive changes, and occurrence of adverse events during the 1-year treatment phase with the DJBL in the German DJBL registry. Methods: Sixty-six patients from the registry were analyzed for efficacy, safety, and nutritional status. Patient data sets were analyzed at implantation, 3 and 6 months after implantation, and at explantation visits. Results: Weight, body mass index, glycated hemoglobin, and low-density lipoprotein cholesterol primarily declined during the first 3 months after implantation, whereas systolic and diastolic blood pressure were predominantly reduced during the second half of the treatment phase. Severe DJBL-associated side effects were mainly documented at the explantation visit (intestinal obstruction [1.7%], dislocation [1.7%], and liver abscess [1.7%]). Measurements of serum concentrations of ferritin, albumin, vitamin B12, folic acid, 25-hydroxyvitamin D3 (25 OH-Vit-D3), and calcium provided suggestive evidence of a possible decrease of nutritional absorption of vitamins and trace elements by the DJBL. Conclusions: The DJBL demonstrates high efficacy with substantial improvement of all parameters of the metabolic syndrome and the potential for reduction of comedications in overweight patients with type 2 diabetes. These registry results are important to optimize recommendations for adaptation of concomitant medication, surveillance of adverse events, nutritional status and supplementation, and adaptation of the implantation period of the DJBL. [Epub 2018 Mar 9] |
URI: | http://hdl.handle.net/20.500.12738/4567 | Einrichtung: | Department Ökotrophologie Fakultät Life Sciences |
Dokumenttyp: | Zeitschriftenbeitrag |
Enthalten in den Sammlungen: | Publications without full text |
Zur Langanzeige
Volltext ergänzen
Feedback zu diesem Datensatz
Export
Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt.